AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Caris Life Sciences, Inc.

$34.33 +$7.35 (+27.24%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$36.14
Day Range
$33.71$35.71
Year Range
$14.19$36.50
Market Cap
9.7B
AVG Volume
4.53M
Trailing/Forward PE
92.31/97.88
PEG ratio
-0.83
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0250M500M750M1B21 Q121 Q221 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CAI Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2989.61M
26 Q1907.29M
25 Q4812.03M
25 Q3649.06M
25 Q2533.85M
25 Q1452.5M
24 Q4412.26M
21 Q3331.64M
21 Q2309.87M
21 Q1299.9M
Net Income (USD) · TTM
-400M-200M0200M21 Q121 Q221 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CAI Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2105.14M
26 Q133.98M
25 Q4-68.09M
25 Q3-186.99M
25 Q2-279.05M
25 Q1-273.44M
24 Q4-281.89M
21 Q3139.08M
21 Q2103.37M
21 Q164.8M
Operating Income (USD) · TTM
-200M-100M0100M200M300M21 Q121 Q221 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CAI Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2153.26M
26 Q1144.32M
25 Q481.09M
25 Q3-44.37M
25 Q2-137.85M
25 Q1-88.83M
24 Q4-123.1M
21 Q3202.11M
21 Q2171.22M
21 Q1153.39M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: CAI

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 4 Nov 2026.

Caris Life Sciences, Inc.
CAI
Stockpicker

Video analysis: CAI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CAI

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.